How to Choose Post-Market Surveillance Software
Seven evaluation criteria, red flags to watch for, the questions that separate marketing from capability, and an evaluation checklist.
Read article →Practical guides on FDA, MHRA, Health Canada and EU MDR compliance, adverse-event and recall monitoring, PSUR reporting, and protecting your devices on the resale market.
Seven evaluation criteria, red flags to watch for, the questions that separate marketing from capability, and an evaluation checklist.
Read article →What the category covers, the four jobs it does, how it differs from a QMS, who uses it, and the one-question test for any tool.
Read article →Why unauthorized resale listings are a safety and liability risk, how devices end up on eBay, DotMed and LabX, and the watchlist-to-takedown workflow that stops them.
Read article →What MHRA, Health Canada, EU Safety Gate, Swissmedic and EUDAMED each publish, why signals surface in one jurisdiction first, and how to consolidate all six sources.
Read article →FSNs vs MHRA alerts, where they're published on GOV.UK, Yellow Card reporting, the GB/Northern Ireland split, and how to monitor UK device safety information post-Brexit.
Read article →A developer's guide to api.fda.gov/device/event.json — search syntax, counting (the .exact rule), pagination, rate limits, API keys and the gotchas, with real working queries.
Read article →How to search the FDA MAUDE database (web search, openFDA API, bulk downloads), scope and run a repeatable monitoring workflow, and the limitations to respect.
Read article →Which EU MDR device classes need a PSUR vs a PMS Report, what goes in each, how often to update them, and who reviews them — with a side-by-side comparison.
Read article →What Articles 83–92 actually require — the PMS system, PMS plan, PSUR, serious-incident reporting timelines and trend reporting, explained in plain terms.
Read article →